David lands $250M Series B at $2.25B, a top 1% raise for the stage
What's the deal? New York-based David, a high-protein food company, has raised a $250 million Series B co-led by Greenoaks Capital Partners and Valor Equity Partners. Iconiq Capital, Imaginary VenturesDealroom has a profile for this one. Try Dealroom →, and company co-founder Peter RahalDealroom has a profile for this one. Try Dealroom → also participated. The round values David at $2.25 billion.
By the numbers: The raise ranks in the top 1% of US food and nutrition Series B rounds over the past 48 months, based on a sample of 98 deals. David has now raised $335 million to date.
What's the endgame? David is best known for its high-protein, low-calorie bars. It has expanded into other protein-focused foods as it builds out a broader product line.
Why now? Consumers continue gravitating toward products marketed around protein and metabolic health. That shift has fuelled demand across the category and given investors a clear thesis to back.
The signal: A quarter-billion-dollar Series B at a multibillion-dollar valuation shows how far capital is flowing into the protein trend. When a single food startup commands a top-percentile round, it signals investors are treating the metabolic health wave as a durable market rather than a passing fad.
Read more: prnewswire.com
Image credit: David
